Under multiple benefits, the pharmaceutical sector in the future market may usher in an inflection point
Time of Update: 2022-11-11
Looking forward to the future market, Huaxia Fund believes that with the steady growth of medical insurance expenditure, the recovery of innovative drug policies and the rationalization of centralized procurement policies, the marginal changes in the industry have changed.
National brands are favored, pleasure is king, health is the trend, and convenience is the key
Time of Update: 2022-08-31
Home, convenient, good-looking, domestic productsThe demands of Generation Z to eat are increasingly diversified The report provides insights into the consumption of food and beverages by the Gen Z group .
7.34 billion euros
Time of Update: 2022-08-19
The Debrecen plant of CATL is close to the OEMs of Mercedes-Benz, BMW, Stellantis, Volkswagen and other customers, which is conducive to CATL to better respond to the needs of the European market and further improve the global Strategic layout to accelerate European electrification and energy transformation .
Baekje, the first listed pharmaceutical company in three places, is coming
Time of Update: 2021-08-09
Although the innovative drugs Baiyueze and Baizean have been launched from January to September 2020, they have achieved sales revenue of nearly 900 million yuan , But at the same time continue to invest in the expansion of the indications of the listed drugs and other new drug research, so the sales of listed drugs are still at a loss .
The fifth batch of national procurement catalogs with a large number of purchases were released, and 60 varieties were shortlisted as the most centralized procurement ever
Time of Update: 2021-07-09
In addition, not all the varieties collected this time met the conditions of consistency evaluation of more than two companies, such as olopatadine hydrochloride, benazepril hydrochloride, budesonide suspension for inhalation, isosorbide mononitrate sustained-release tablets, At present, only two of more than ten varieties, such as iohexol injection and dutasteride soft capsules, have been reviewed, and this also means that the intensity of centralized procurement has been further accelerated .
Analysis of the market status and development trends of the chemical industry in Shandong Province in 2021, the country's largest chemical province leading the transformation of the industry
Time of Update: 2021-06-08
Chart 3: Distribution of chemical industry clusters in Shandong Province Regulations on chemical industry revenue accounted for nearly 30% of the country In 2020, the operating income of the national chemical industry above designated size was 6.
Tribute 2021| Build China's Pharmaceutical Innovation Ecosystem - The first in a series of reports: 2015-2020 Development Review and Future Outlook" was officially released
Time of Update: 2021-03-23
202132，（PhIRDA）（RDPAC），《——：2015-2020》（“”）。《》，、、（、）、，，，、，。，“”（），《》。 2020 is the final year of the major scientific and technological projects of "Major New Drug Development"; 2021 is the beginning yea
Powder coatings are included in the 2018 National Strategic Emerging Industries Key Products and Services Catalog
Time of Update: 2020-12-02
, powder coatings are listed as strategic emerging industries - new materials industry under the paint manufacturing classification of key products and services.
1 Strategic Emerging Industries Classification Table - Coatings Manufacturing Table 2 Key Products and Services Catalog - Paint Manufacturing
The third quarterly report of local pharmaceutical companies: who is the most powerful innovative drug? 4 + 7 influence geometry
Time of Update: 2019-10-31
It's time to take stock of the achievements of various pharmaceutical companies As of October 28, 2019, 157 companies in the pharmaceutical and biological sector have published the third quarter repor
Five main problems in the development of biomedicine in China
Time of Update: 2015-01-06
Introduction: Recently, Xu Ming, vice president of China Chamber of Commerce for the import and export of healthcare products, told the new drug exchange reporter at the pre conference preparatory mee
The real barriers to genetic testing: big data and high-end talent
Time of Update: 2014-07-16
Source: Zhang Shangbin / securities market weekly on July 16, 2014 suddenly came like a spring breeze overnight Gene sequencing companies have been enthusiastically sought after in the capital markets